MRK
Merck Sharp & Dohme LLC
Phase 2
Estimated
Tulisokibart
Hidradenitis Suppurativa
T-minus 13 days
Nov 16, 2026
ClinicalTrials.gov
verified 4mo ago
Countdown card β